Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Left ventricular volume predicts exercise capacity in hypertrophic cardiomyopathy.
Axelsson A, Iversen K, Vejlstrup N, Langhoff L, Thomsen A, Ho CY, Havndrup O, Kofoed KF, Jensen M, Bundgaard H. Axelsson A, et al. Among authors: jensen m. Int J Cardiol. 2016 Jan 15;203:676-8. doi: 10.1016/j.ijcard.2015.11.029. Epub 2015 Nov 6. Int J Cardiol. 2016. PMID: 26583841 No abstract available.
Efficacy and safety of the angiotensin II receptor blocker losartan for hypertrophic cardiomyopathy: the INHERIT randomised, double-blind, placebo-controlled trial.
Axelsson A, Iversen K, Vejlstrup N, Ho C, Norsk J, Langhoff L, Ahtarovski K, Corell P, Havndrup O, Jensen M, Bundgaard H. Axelsson A, et al. Among authors: jensen m. Lancet Diabetes Endocrinol. 2015 Feb;3(2):123-31. doi: 10.1016/S2213-8587(14)70241-4. Epub 2014 Dec 19. Lancet Diabetes Endocrinol. 2015. PMID: 25533774 Clinical Trial.
MT-CYB mutations in hypertrophic cardiomyopathy.
Hagen CM, Aidt FH, Havndrup O, Hedley PL, Jespersgaard C, Jensen M, Kanters JK, Moolman-Smook JC, Møller DV, Bundgaard H, Christiansen M. Hagen CM, et al. Among authors: jensen m. Mol Genet Genomic Med. 2013 May;1(1):54-65. doi: 10.1002/mgg3.5. Epub 2013 Apr 12. Mol Genet Genomic Med. 2013. PMID: 24498601 Free PMC article.
The KCNE genes in hypertrophic cardiomyopathy: a candidate gene study.
Hedley PL, Haundrup O, Andersen PS, Aidt FH, Jensen M, Moolman-Smook JC, Bundgaard H, Christiansen M. Hedley PL, et al. Among authors: jensen m. J Negat Results Biomed. 2011 Oct 3;10:12. doi: 10.1186/1477-5751-10-12. J Negat Results Biomed. 2011. PMID: 21967835 Free PMC article.
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial.
Olivotto I, Oreziak A, Barriales-Villa R, Abraham TP, Masri A, Garcia-Pavia P, Saberi S, Lakdawala NK, Wheeler MT, Owens A, Kubanek M, Wojakowski W, Jensen MK, Gimeno-Blanes J, Afshar K, Myers J, Hegde SM, Solomon SD, Sehnert AJ, Zhang D, Li W, Bhattacharya M, Edelberg JM, Waldman CB, Lester SJ, Wang A, Ho CY, Jacoby D; EXPLORER-HCM study investigators. Olivotto I, et al. Among authors: jensen mk. Lancet. 2020 Sep 12;396(10253):759-769. doi: 10.1016/S0140-6736(20)31792-X. Epub 2020 Aug 29. Lancet. 2020. PMID: 32871100 Clinical Trial.
Alcohol septal ablation in patients with severe septal hypertrophy.
Veselka J, Jensen M, Liebregts M, Cooper RM, Januska J, Kashtanov M, Dabrowski M, Hansen PR, Seggewiss H, Hansvenclova E, Bundgaard H, Ten Berg J, Hilton Stables R, Faber L. Veselka J, et al. Among authors: jensen m. Heart. 2020 Mar;106(6):462-466. doi: 10.1136/heartjnl-2019-315422. Epub 2019 Aug 30. Heart. 2020. PMID: 31471463
5,441 results